Physician profile
Lawrence Tsai
NPI 1366853152
$7,143.31
in general payments reported to CMS, 2019-2025
37 companies · $411 in 2025
The $411 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,422 · 2020: $1,383 · 2021: $991 · 2022: $1,439 · 2023: $959 · 2024: $538 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,968.50 | 2020-2023 | Axonics |
| Boston Scientific Corporation | $1,724.62 | 2019-2024 | Rezum Generator, Spaceoar Vue System - 10ml, Ams 700 |
| Abbvie INC. | $517.27 | 2022-2025 | Botox |
| Neotract INC. | $426.79 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $367.80 | 2019-2024 | Aveed, Xiaflex |
| Teleflex LLC | $258.51 | 2020-2025 | Urolift, Barrigel |
| Allergan, INC. | $229.14 | 2019-2022 | |
| 180 Medical, INC. | $204.09 | 2023-2024 | Cure Catheter, Gentlecath Glide |
| Sumitomo Pharma America, INC. | $160.96 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $138.07 | 2019-2025 | |
| Medtronic, INC. | $97.17 | 2022 | |
| Clarus Therapeutics INC. | $93.47 | 2021 | |
| Ferring Pharmaceuticals INC. | $77.99 | 2024-2025 | Adstiladrin |
| Astellas Pharma US INC | $69.95 | 2020-2023 | Xtandi |
| Abbott Laboratories | $66.29 | 2023 | Octrode |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $65.77 | 2022-2023 | Ecoin Device Kit |
| Acerus Pharmaceuticals Corporation | $65.28 | 2021-2022 | |
| Urogen Pharma, INC. | $61.81 | 2021-2025 | Jelmyto |
| Coloplast Corp | $58.12 | 2023-2024 | Altis |
| Procept Biorobotics Corporation | $55.74 | 2020-2024 | Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $52.23 | 2024-2025 | |
| Myovant Sciences INC. | $40.78 | 2021 | |
| Endo USA, INC. | $39.89 | 2024-2025 | Xiaflex, Aveed |
| Halozyme INC | $31.97 | 2023 | |
| Convatec INC. | $27.93 | 2023 | |
| Novartis Pharmaceuticals Corporation | $27.58 | 2023 | |
| Laborie Medical Technologies Corp. | $24.95 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Argon Medical Devices, INC. | $23.70 | 2024 | Clot Management |
| Smith+Nephew, INC. | $23.23 | 2023 | Stravix Pl |
| Ethicon US, LLC | $21.03 | 2019 | |
| Genzyme Corporation | $20.55 | 2020 | |
| Accord Healthcare, INC. | $19.71 | 2023 | |
| Conmed Corporation | $19.62 | 2021 | |
| Aytu Biopharma, INC. | $19.40 | 2019 | |
| Janssen Biotech, INC. | $17.03 | 2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $15.16 | 2023 | Prolaris |
| Lupin INC. | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.